Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-04-06FDA Approved: TIMOPTIC IN OCUDOSE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for TIMOPTIC IN OCUDOSE (timolol maleate) submitted by Bausch & Lomb Incorporated.
-
FDA approval · 2017-02-01FDA Approved: BETOPTIC S — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for BETOPTIC S (betaxolol hydrochloride), a beta-blocker ophthalmic solution. The product is manufac…
-
FDA approval · 2016-08-09FDA Approved: TIMOPTIC — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for Timoptic (timolol maleate) from Bausch & Lomb, authorizing updates to the product via an NDA sup…
-
FDA approval · 2016-08-05FDA Approved: BETAXOLOL HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for betaxolol hydrochloride by Sandoz Inc, updating its labeling/approval for use in open-angle glau…
-
FDA approval · 2016-05-05FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for ALPHAGAN P (brimonidine tartrate), approving changes to the product labeling requested by Allerg…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-04-22FDA Approved: LATANOPROST — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved a generic latanoprost product from Rising Pharma Holdings, Inc. via an Original Application (ANDA 202442) to reduce intraoc…
-
FDA approval · 2016-04-19FDA Approved: BIMATOPROST — Original Application (Sandoz Inc)
FDA approved the original ANDA for bimatoprost ophthalmic solution by Sandoz, establishing a generic version of this glaucoma medication.
-
FDA approval · 2016-01-19FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brimonidine tartrate submitted by Sandoz Inc, resulting in changes to the product's labeling…
-
FDA approval · 2015-12-09FDA Approved: LATANOPROST — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for latanoprost filed by Bausch & Lomb Incorporated.
-
FDA approval · 2015-11-27FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd.)
The FDA approved Advagen Pharma Ltd.'s supplemental application for dorzolamide hydrochloride, authorizing a generic version of the drug.
-
FDA approval · 2015-11-10FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brinzolamide submitted by Sandoz Inc under NDA 020816, reflecting an approved modification t…
-
FDA approval · 2015-11-10FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brimonidine tartrate submitted by Sandoz Inc.
-
FDA approval · 2015-11-05FDA Approved: IOPIDINE 1% — Supplemental Application (Harrow Eye, LLC)
The FDA approved a supplemental application to market IOPIDINE 1% (apraclonidine hydrochloride ophthalmic solution) under Harrow Eye, LLC. T…
-
FDA approval · 2015-11-05FDA Approved: SIMBRINZA — Supplemental Application (Alcon Laboratories, Inc.)
FDA approved a supplemental application for SIMBRINZA (brinzolamide/brimonidine tartrate) submitted by Alcon Laboratories, Inc.
-
FDA approval · 2015-10-15FDA Approved: COMBIGAN — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for COMBIGAN (brimonidine tartrate, timolol maleate) submitted by Allergan, Inc., updating the produ…
-
FDA approval · 2015-10-08FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb Incorporated.
-
FDA approval · 2015-10-06FDA Approved: TIMOLOL MALEATE — Supplemental Application (Pacific Pharma, Inc.)
The FDA approved a supplemental application for Timolol Maleate from Pacific Pharma, Inc., under an approved supplemental submission.
-
FDA approval · 2015-09-04FDA Approved: TAFLUPROST OPHTHALMIC — Supplemental Application (Prasco Laboratories)
FDA notes a supplemental application for Tafluprost Ophthalmic (TAFLUPROST) submitted by Prasco Laboratories. The document indicates the sta…
-
FDA approval · 2015-07-31FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)
FDA approved a supplemental application for COSOPT (dorzolamide hydrochloride and timolol maleate) submitted by Thea Pharma Inc. The product…
-
FDA approval · 2015-07-20FDA Approved: BIMATOPROST — Original Application (Apotex Corp.)
FDA approved the original application for bimatoprost from Apotex Corp, granting approval for a generic ophthalmic solution. Bimatoprost is …
-
FDA approval · 2015-07-10FDA Approved: TRAVOPROST — Original Application (Apotex Corp.)
The FDA approved Apotex Corp.'s original application for Travoprost, a generic eye drop used to lower intraocular pressure in glaucoma and o…
-
FDA approval · 2015-05-11FDA Approved: BETAXOLOL HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for betaxolol hydrochloride from Sandoz Inc.
-
FDA approval · 2014-12-19FDA Approved: BETAXOLOL — Supplemental Application (Epic Pharma LLC)
The FDA approved a supplemental application (ANDA075541) for Betaxolol from Epic Pharma LLC, marking an approved change under the ANDA proce…
-
FDA approval · 2014-11-25FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for latanoprost from Mylan Pharmaceuticals Inc., supporting a generic latanoprost product. This …
-
FDA approval · 2014-11-18FDA Approved: BRIMONIDINE TARTRATE — Original Application (Florida Pharmaceutical Products, LLC)
FDA approved Brimonidine tartrate from Florida Pharmaceutical Products, LLC under an Original Application (ANDA), enabling its entry as a ge…